CLNN.NASDAQClene INC
Form 4: Clene Inc. Chief Science Officer Mark Mortenson Acquires Shares and Warrants
Sentiment:
SEC Form 4
Clene Inc.'s Chief Science Officer, Mark Mortenson, recently acquired shares and warrants of the company's common stock.
Summary
- On September 30, 2024, Mark Mortenson, the Chief Science Officer of Clene Inc., acquired 20,512 shares of common stock at a price of $4.75 per share.
- Following this transaction, Mortenson directly owns 28,949 shares of Clene Inc. common stock.
- Mortenson also acquired warrants to purchase 20,512 shares of common stock at an exercise price of $4.82, exercisable from October 1, 2024, to October 1, 2029.
- The price of the warrants was $0.125.
- A 1-for-20 reverse stock split occurred on July 11, 2024, which reduced Mortenson's previously held shares from 168,759 to 8,437.
Sentiment
Score: 5
Explanation: The document simply reports a transaction. It's neutral in sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Clene Inc. common stock underwent a 1-for-20 reverse stock split. |
| 09/30/2024 | Mark Mortenson acquired common stock and warrants. |
| 10/01/2024 | Date of Report. |
| 10/01/2024 | Warrants become exercisable. |
| 10/01/2029 | Warrants expiration date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.